Resources

Results 901 - 925 of 1057

In February and March 2016, a team of MSH staff and consultants collaborated with the MOHS,UNICEF/Sierra Leone, and other stakeholders to collect data for piloting the methodology and tool.MSH staff conducted interviews and collected data at all levels of the health system, including visitsto health facilities in two districts where facility staff, CHW supervisors, and CHWs were interviewed.MSH st

MSH designed and piloted this methodology and tool in Malawi and Sierra Leone, countries that were selected given the important role that community health workers play within each of the countries' health systems.

We interviewed 273 HIV-infected adolescents receiving antiretroviral therapy (ART) from three hospitals in Addis Ababa. The level of self-reported ART adherence among HIV-infected adolescents at the three hospitals was below the recommended threshold. Though earlier presentation of adolescents to care should be encouraged, more targeted adherence support should be planned for those who present at an early stage of their illness.

Bedaquiline (BDQ) has been recommended by the World Health Organization for the treatment of multidrug-resistant tuberculosis (MDR-TB) since 2013, but experience using the drug in high-burden, lower-income countries is limited and case studies are needed. Swaziland started using BDQ under national TB programme conditions in 2015 in four pilot sites. As of 1 December 2016, 93 patients had been initiated on BDQ, i.e., 19% of MDR-TB patients treated in the country. Swaziland has developed a systematic and efficient model for BDQ introduction in collaboration with several partners. This model is also being used to introduce other innovations and can serve as an example for other countries facing similar challenges.

This conceptual framework was designed to show the influence gender has on supervisor-provider relationships, and how this influence could be explored and addressed through programming and research.

Strong leadership and good governance practices are critical factors for epidemic preparedness and response.

Inside this issue: Enabling Proper Quantification of Essential Medicines Improved Coordination to Enhance Contraceptive Availability Establishing Common Criteria for Monitoring Supplier Performance Launching a New Pharmaceutical Logistic Information System Technical Sessions Continue to Promote Knowledge Sharing Public Sector Pharmaceutical Services Directory Released

The safety, efficacy, and quality of pharmaceutical products can be highly affected by the lack of adequate controls on importation. It is therefore imperative that the importation of pharmaceutical products conforms to certain set standards. In this context, the importation of pharmaceutical products should not be treated in the same way as ordinary commodities.

Afghanistan already has a pharmaceutical product waste disposal operation, and pharmaceutical materials are reviewed for disposal and destruction, but the current operation is generally believed to have many shortfalls. Attempts at estimating the scale of the issue using total throughput volumes of pharmaceuticals have indicated no major issue on waste disposal because not enough volume of ph

The goals of this new edition of the National Medicines Policy are to ensure the continuous development of the pharmaceutical sector and to meet the health care pharmaceutical requirements of all people living in Afghanistan, through the provision and use of safe, efficacious, high quality, cost effective, and affordable medicines and related products.

Building and strengthening health systems are difficult and take time.

Inside this issue: SPS Afghanistan Associate Award Stakeholders Update Pharmacy Curriculum National Food & Medicine Board Hosts Workshop Welcome from the Chief of Party   SPS & GDPA Attend International Conference SPS Assists MoPH with Emergency Medicine Order   Heath Communications Message Widely Broadcasted Transition of Drug Management Unit Completed

The Ministry of Public Health (MoPH), with technical and financial assistance of the Strengthening Pharmaceutical Systems (SPS) project funded by the US Agency for International Development (USAID), carried out the medicines safety assessment from March to August 2013 in six Kabul hospitals.

In Afghanistan, 20 non-governmental organizations are contracted by the Ministry of Public Health (MOPH) to provide support to the Basic Package for Health Services and Essential Package for Hospital Services (BPHS/EPHS) in all 34 provinces. The Pharmaceutical Logistics Information System (PLIS) was tested in all these NGOs in all the provinces in September 2013.

This national standard treatment guidelines (STGs) manual is designed for use at the first-level (i.e., primary) facilities delivering the Basic Package of Health Services (BPHS).

The General Directorate of Pharmaceutical Affairs (GDPA) operates within the Ministry of Public Health (MOPH) in Afghanistan and is the prime body for managing pharmaceutical activities within the country in both the public and private sectors. MOPH recognizes the current difficulties on essential medicines and wishes to see a harmonized and integrated approach with a nationally coordinated m

The pharmaceutical regulatory situation in Afghanistan is generally considered to be weak with most of the activities in the private sector and, to a l arge extent, in the public sector largely uncontrolled.

This framework seeks to outline a national strategy for the development of pharmaceutical HR in the public and private sectors in Afghanistan to produce a stronger pharmaceutical system that responds to the population’s needs.

The pharmaceutical services competency framework defines competencies for core tasks in each area. Expert practitioners in each of the service areas identified the main tasks.

For largely historical reasons of development in a post- or ongoing conflict situation, the current essential medicines supply mechanisms in Afghanistan are characterized by multiple funding sources and a large number of active players, giving rise to fragmented and, currently, largely uncoordinated service from multiple, vertical supply streams of varying efficiency. This is not to say that

The Afghanistan Ministry of Public Health (MoPH), with technical assistance from the Strengthening Pharmaceutical Systems (SPS) Program, carried out a survey of medicines quality in Afghanistan. The survey was conducted for the MoPH to determine whether medicines in the public and private sectors of Afghanistan comply with established international pharmacopeial standards.

The Afghanistan Ministry of Public Health (MoPH) with technical assistance from the Strengthening Pharmaceutical Systems (SPS) Program carried out a qualitative survey of medicines quality assurance assessment in Afghanistan.

The MoPH established the National Medicines and Food Board (NMFB) in 2009, as a multidisciplinary body to oversee and catalyze regulatory activities in medicines and food products.

This medicine use study was planned, conducted, and analyzed by the Strengthening Pharmaceutical Systems (SPS) Program of Management Sciences for Health (MSH) in collaboration with the Ministry of Public Health (MoPH). Data collection for the study was conducted in March and April, 2009.

SPS conducted an initial assessment of the existing regulatory mechanisms and systems for food and medicinal products with the goal of proposing options and approaches for a well-developed regulatory framework. The assessment team interviewed 24 stakeholders related to food and medicine regulation (7 food-specific, 6 medicines-specific, and 11 related to both). 

Pages

Printer Friendly Version